Testing effectiveness (Phase 2)Study completedNCT01509560
What this trial is testing
PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
Who this might be right for
Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21